Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Kurt HuberDepartment of Cardiology, Wilhelminen HospitalVienna, Austria
Department of Cardiology, Glenfield Hospital, University of LeicesterUnited Kingdom
About the formatThe ESC Webinars are designed to help you improve your daily practice!The format includes a case based presentation, online assessment and live discussions with the 2 key opinion leaders who will give you some useful tips for your daily clinical practice.
Professor Huber presents and Professor Gershlick hosts this webinar on:Challenges in antiplatelet therapy after ACS: the best alternatives for short and long term management?The choice of the best antiplatelet therapy after an acute coronary syndrome can be challenging, especially in a new era with new antiplatelet agents and different possible combinations.
In this webinar, based on the presentation of different clinical scenarios of patients after ACS, the best antiplatelet therapy alternative (and duration) will be discussed, for both short and long term management.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903 Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved